Listed

Standard Biotools Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 9, 2015 and accepted by EDGAR at Nov 9, 2015, 15:46 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$28.6mus-gaap:Revenues
Revenue9 months2015-01-01 to 2015-09-30$84.0mus-gaap:Revenues
Cost of revenue3 months2015-07-01 to 2015-09-30$10.5mus-gaap:CostOfGoodsSold
Cost of revenue9 months2015-01-01 to 2015-09-30$31.5mus-gaap:CostOfGoodsSold
Research and development3 months2015-07-01 to 2015-09-30$9.4mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$29.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-07-01 to 2015-09-30$19.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2015-01-01 to 2015-09-30$60.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-07-01 to 2015-09-30−$7.8mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$36.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2015-07-01 to 2015-09-30$1.5mus-gaap:InterestExpense
Interest expense9 months2015-01-01 to 2015-09-30$4.4mus-gaap:InterestExpense
Income tax3 months2015-07-01 to 2015-09-30−$362.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2015-01-01 to 2015-09-30−$1.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-07-01 to 2015-09-30−$9.3mus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$40.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.32us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$1.41us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2015-01-01 to 2015-09-30−$30.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2015-01-01 to 2015-09-30$2.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-09-30$28.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$145.4mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$378.5mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$27.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$254.4mus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$124.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-15-000154. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.